Related Experiment Video
Updated: Jul 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study
Teemu J Niiranen1, Bindu Kalesan2,3, Naomi M Hamburg4,5,6
1National Heart, Blood and Lung Institute's and Boston University's Framingham Heart Study, Framingham, MA teemu.niiranen@thl.fi.
Insights
High arterial stiffness is common in treated hypertensive patients, contributing to residual cardiovascular disease (CVD) risk. Arterial stiffness measurements may help assess CVD risk in both hypertensive and non-hypertensive individuals.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Vascular Biology
Background:
- Arterial stiffness is a potential predictor of outcomes, but its role in community-dwelling treated hypertensives is unclear.
- Limited data exist on arterial stiffness and cardiovascular disease (CVD) risk across the full blood pressure spectrum.
Purpose of the Study:
- To investigate the prevalence and implications of abnormal arterial stiffness in treated hypertensives.
- To examine the association between arterial stiffness and CVD risk across varying blood pressure levels.
Main Methods:
- Carotid-femoral pulse wave velocity (PWV) and CVD risk factors were measured in 2127 Framingham Offspring Cohort participants.
- Participants were categorized by hypertension status and PWV (high/low) and followed for CVD events over a median of 12.6 years.
Main Results:
- A high prevalence of elevated PWV was observed in treated hypertensives (60% controlled, 90% uncontrolled).
- Multivariable-adjusted CVD event risk increased progressively from normotension with low PWV to hypertension with high PWV (HR 2.25).
Conclusions:
- Elevated arterial stiffness is frequent in treated hypertensives, potentially explaining residual CVD risk.
- High PWV is associated with increased CVD risk in both hypertensive and non-hypertensive individuals, suggesting clinical utility for its measurement.
Background:
The presence and implications of abnormal arterial stiffness, a potential independent predictor of outcomes, in community-dwelling treated hypertensives is unknown. Furthermore, limited data exist regarding the risk of cardiovascular disease (CVD) associated with arterial stiffness across the entire range of blood pressure.
Methods And Results:
We measured carotid-femoral pulse wave velocity (PWV) and classical CVD risk factors in 2127 community-dwelling participants (mean age 60 years, 57% women) of The Framingham Offspring Cohort. The participants were divided into 4 groups according to hypertension (yes/no, defined as blood pressure ≥140/90 mm Hg or use of antihypertensive treatment) and PWV status (high/low based on age- and sex-specific median values) and followed up for CVD events (CVD death, myocardial infarction, unstable angina, heart failure, and stroke). Sixty percent (233 of 390) of controlled and 90% (232 of 258) of uncontrolled treated hypertensives had high PWV. The multivariable-adjusted risk for CVD events (n=248, median follow-up 12.6 years) rose from normotension with low PWV (reference) to normotension with high PWV (hazard ratio 1.29, 95% CI 0.83-2.00) and from hypertension with low PWV (hazard ratio 1.54, 95% CI 1.01-2.36) to hypertension with high PWV (hazard ratio 2.25, 95% CI 1.54-3.29).
Conclusions:
A substantial proportion of treated hypertensives have high arterial stiffness, a finding that may explain some of the notable residual CVD risk associated with even well-controlled hypertension. High PWV is associated with a trend towards increasing CVD risk in both nonhypertensives and hypertensives, a finding that may support the use of arterial stiffness measurements in both populations.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

